Welcure Drugs & Pharmaceuticals P/E Ratio
Welcure Drugs & Pharmaceuticals (WELCURE) P/E ratio is 1.17 (Low), EPS (TTM) ₹0.36, current price ₹0.32 on BSE — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see WELCURE stock price BSE.
Current P/E Ratio
1.17
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
1.17
Current Price
₹0.32
EPS (TTM)
₹0.36
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
49.6
Sector Median
27.32
Sector Rank
#1 of 139
Sector Percentile
0.7%
WELCURE P/E Ratio — Valuation Signal & Historical Context
Welcure Drugs & Pharmaceuticals P/E 1.17 — signal: Undervalued. Analyse Welcure Drugs & Pharmaceutical ownership structure to track promoter, FII and institutional holdings.
- Stock appears undervalued with PE of 1.17, suggesting potential buying opportunity
- Trading at discount to sector average PE of 49.6
WELCURE vs Healthcare Peers — P/E Ratio Comparison
Welcure Drugs & Pharmaceuticals P/E 1.17 vs Healthcare average 49.6, median 27.32 — range 2.86–869.57.
Sector Average
49.6
Sector Median
27.32
Lowest P/E
2.86
Highest P/E
869.57
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 6.78 | ₹73 | Low |
| Zenith Drugs | ZENITHDRUG | 7.55 | ₹73 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Medicamen Organics | MEDIORG | 8.01 | ₹32 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Vasundhara Rasayans | VRL | 11.05 | ₹40 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 11.46 | ₹152 | Low |